Illumina shares owned by Gateway Investment Advisers
Quarter-by-quarter ownership of Illumina (ILMN) shares owned by Gateway Investment Advisers
from 13F filings
Historical chart of Gateway Investment Advisers investment in Illumina
Tip: Access up to 7 years of quarterly data
All positions including Illumina held by Gateway Investment Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Illumina by Gateway Investment Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $6.1M | 45k | 137.28 |
2023-06-30 | $10M | 54k | 187.49 |
2023-03-31 | $12M | 51k | 232.55 |
2022-12-31 | $14M | 67k | 202.20 |
2022-09-30 | $13M | 67k | 190.78 |
2022-06-30 | $15M | 79k | 184.36 |
2022-03-31 | $22M | 63k | 349.40 |
2021-12-31 | $24M | 63k | 380.43 |
2021-09-30 | $25M | 63k | 405.60 |
2021-06-30 | $30M | 62k | 473.21 |
2021-03-31 | $24M | 63k | 384.05 |
2020-12-31 | $23M | 63k | 369.99 |
2020-09-30 | $23M | 73k | 309.08 |
2020-06-30 | $32M | 87k | 370.35 |
2020-03-31 | $27M | 100k | 273.12 |
2019-12-31 | $24M | 72k | 331.74 |
2019-09-30 | $23M | 76k | 304.22 |
2019-06-30 | $31M | 85k | 368.15 |
2019-03-31 | $26M | 85k | 310.69 |
2018-12-31 | $26M | 85k | 299.93 |
2018-09-30 | $29M | 79k | 367.06 |
2018-06-30 | $22M | 79k | 279.29 |
2018-03-31 | $19M | 80k | 236.42 |
2017-12-31 | $21M | 96k | 218.49 |
2017-09-30 | $18M | 93k | 199.20 |
2017-06-30 | $17M | 100k | 173.52 |
2017-03-31 | $18M | 107k | 170.64 |
2016-12-31 | $14M | 112k | 128.04 |
2016-09-30 | $20M | 108k | 181.66 |
2016-06-30 | $18M | 126k | 140.38 |
2016-03-31 | $19M | 114k | 162.11 |
2015-12-31 | $24M | 124k | 191.95 |
2015-09-30 | $7.0M | 40k | 175.82 |
2015-06-30 | $7.8M | 36k | 218.36 |
2015-03-31 | $6.4M | 35k | 185.65 |
2014-12-31 | $6.3M | 34k | 184.59 |
2014-09-30 | $3.5M | 21k | 163.90 |
2014-06-30 | $3.7M | 21k | 178.55 |
More positions owned by Gateway Investment Advisers
Home Depot (HD)
View all positions for Gateway Investment Advisers